|
NevoMD brings AI-assisted clinical reasoning to complex medical case analysis.
|
NevoMD launched in Q1 2026 and is expanding its technology and operations worldwide.
NevoMD is currently privately funded and is looking to expand through strategic seed investment. If you represent a private or public seed investment firm and are interested in learning more, please contact us through our Contact form.